## Abstract Antibody activity to Herpes simplex virus typeβ1 (HSVβ1) and typeβ2 (HSVβ2) was measured by the indirect hemagglutination (IHA) test in sera from 124 women with squamousβcell carcinoma of the uterine cervix, 46 women with nonβcervical cancer and 116 matched normal women. The typeβspecif
Tubular structures in the cervix of mice experimentally infected with herpes simplex virus type 2
β Scribed by Tsuyoshi Iwasaka; Hiroshi Oda; Yuwao Hino; Ryoichi Mori
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 753 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Experimental infection of the C3H/N mouse genital tract was demonstrated after intravaginal inoculation with herpes simplex virus type 2 (HSVβ2). About 75% of the infected animals died by Day 7, and 75% of the surviving animals had severe vaginitis or neurological signs on Day 7. Titers of the virus recovered from vaginal secretions of infected animals reached a maximum on Day 2 and gradually decreased until Day 7. On the other hand, under the electron microscope, virus particles and tubular structures could be found in the nuclei of infected cells of the cervix in the 1st, 2nd and 4th days after infection. All cases in which virus particles could be found in the nuclei of infected cells were also positive for tubular structures and vice versa. These observations indicate that in situ diagnosis of HSVβ2 infection can be made in the mouse model. The same method would be applicable for the diagnosis of human HSVβ2 infection.
π SIMILAR VOLUMES
## Abstract The in vivo antiviral activity of the Keggin polyoxotungstate PMβ19 [K~7~(PTi~2~W~10~O~40~) Β· 6H~2~O] against herpes simplex virus type 2 (HSVβ2) was investigated in mice immunosuppressed by cyclophosphamide (CY). When PMβ19 was administered intraperitoneally to immunosuppressed mice fo
Adult BALB/c mice, genetically resistant to HSV-1 i.p. infection, were inoculated intraperitoneally with 1000 PFU of HSV-1 and treated by the same route with four consecutive doses of Melia azedarach L. aqueous green leaves extract (MA) each containing 80 antiviral units against HSV-1 replication in
A human leukocyte antigen (HLA)-matched unrelated bone marrow transplantation (BMT) was performed in a 13-year-old patient with the congenital immunodeficiency syndrome, Wiskott-Aldrich syndrome. The patient had a history of acyclovir (ACV)-resistant (ACV(r)) herpes simplex virus type 1 (HSV-1) infe